Need for hepatitis A prevention in patients with chronic liver disease in the changing epidemiological setting of India

Need for hepatitis A prevention in patients with chronic liver disease in the changing epidemiological setting of India

The burden of chronic liver disease (CLD) in India is high, particularly among middle-aged men, with nearly 220,000 deaths due to cirrhosis in 2017. CLD increases the risk of infection, severe disease (e.g. hepatitis A virus or HAV superinfection, acute-on-chronic liver failure, fulminant hepatic fa...

Full description

Bibliographic Details
Main Authors: Bhaskar Raju, Anar Andani, Shafi Kolhapure, Ashish Agrawal
Format: Article
Language:English
Published: Taylor & Francis Group 2021-05-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
hepatitis a
chronic liver disease
cirrhosis
india
vaccination
endemicity
Online Access:http://dx.doi.org/10.1080/21645515.2020.1832408

Similar Items

Similar Items